SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 396 filers reported holding SEATTLE GENETICS INC in Q3 2020. The put-call ratio across all filers is 0.61 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $1,412,000 | +53.1% | 8,310 | +4.2% | 0.11% | +27.1% |
Q1 2020 | $922,000 | -2.6% | 7,973 | -3.7% | 0.08% | +23.2% |
Q4 2019 | $947,000 | +21.6% | 8,277 | -9.2% | 0.07% | +4.5% |
Q3 2019 | $779,000 | +21.7% | 9,117 | -1.3% | 0.07% | +34.7% |
Q2 2019 | $640,000 | -5.5% | 9,238 | 0.0% | 0.05% | +2.1% |
Q1 2019 | $677,000 | +26.5% | 9,238 | 0.0% | 0.05% | +20.0% |
Q4 2018 | $535,000 | -24.9% | 9,238 | 0.0% | 0.04% | -25.9% |
Q3 2018 | $712,000 | +128.2% | 9,238 | +96.6% | 0.05% | +125.0% |
Q2 2018 | $312,000 | – | 4,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,046,060 | $2,892,270,000 | 23.68% |
Lagoda Investment Management, L.P. | 88,615 | $5,021,000 | 8.38% |
Matrix Capital Management Company, LP | 3,141,852 | $178,017,000 | 5.90% |
Opus Point Partners Management, LLC | 19,127 | $1,084,000 | 2.39% |
EMORY UNIVERSITY | 41,539 | $2,354,000 | 1.86% |
Capital International Sarl | 238,100 | $13,491,000 | 1.62% |
Rhenman & Partners Asset Management AB | 242,198 | $13,723,000 | 1.57% |
CAPITAL GUARDIAN TRUST CO | 1,341,050 | $75,984,000 | 1.21% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 42,500 | $1,890,000 | 1.17% |
JGP Global Gestao de Recursos Ltda. | 16,524 | $936,000 | 1.14% |